4/A//SEC Filing
Sorsher Gary I. 4/A
Accession 0001209191-12-047489
CIK 0001013606other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 3:36 PM ET
Size
5.6 KB
Accession
0001209191-12-047489
Insider Transaction Report
Form 4/AAmended
Sorsher Gary I.
Vice President - Quality
Transactions
- Award
Common Stock
2012-09-09$12.62/sh+28,944$365,273→ 54,140 total
Footnotes (5)
- [F1]25% vesting to occur upon the achievement of Nellix device revenue target for a month.
- [F2]25% vesting to occur upon U.S. regulatory approval of Nellix device.
- [F3]25% vesting to occur upon U.S. regulatory approval of Ventana device.
- [F4]25% vesting to occur upon U.S.regulatory approval of a second-generation AFX device.
- [F5]100% cliff vesting to occur 9/9/2016 in the event milestones are not achieved.
Documents
Issuer
ENDOLOGIX INC /DE/
CIK 0001013606
Entity typeother
Related Parties
1- filerCIK 0001446968
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 3:36 PM ET
- Size
- 5.6 KB